Articles related to CONTRACEPTION/BIRTH CONTROL

New research indicates that maternal hemoglobin levels can significantly impact both maternal and neonatal health outcomes, suggesting a need for revised antenatal care guidelines.

Melasma is a complex condition with dermatological and psychological implications; early recognition and preventive measures can significantly impact patient outcomes. Learn more about the role primary care physicians can play in managing this challenging condition.

The FDA’s approval of Zurzuvae (zuranolone) as the first oral treatment for postpartum depression represents a significant advancement in patient care. Physicians are encouraged to explore this new option, considering both its proven efficacy and accompanying warnings, to provide more accessible care for those struggling with this serious condition.

This review delves into the neurological consequences of preterm birth, highlighting the particular brain impairments and developmental obstacles that survivors experience. Learn about the most recent advances in advanced neuroimaging and potential treatments to improve outcomes.

FDA’s approval of Opill, the first over-the-counter daily oral contraceptive, marks a major shift in contraceptive accessibility, opening new pathways in the prevention of unintended pregnancies.

As the FDA approves the first over-the-counter oral contraceptive, dental professionals must be cognizant of potential impacts on oral health and patient management.